Thermo Fisher Scientific Share Price (NYSE: TMO)

$488.59

▲

-2.16

(-0.44%)

Last updated on August 27, 2025 at 1:29 AM IST

$₹

Check the interactive Thermo Fisher Scientific Stock chart to analyse performance

Thermo Fisher Scientific stock performance

as on August 27, 2025 at 1:29 AM IST

Today's Low:$487.00
Today's High:$491.18
$488.59
0.33%
Downside
Day's Volatility :0.85%
Upside
0.53%
52 Weeks Low:$385.46
52 Weeks High:$627.88
$488.59
21.11%
Downside
52 Weeks Volatility :38.61%
Upside
22.18%

Thermo Fisher Scientific Stock Returns

Period	Thermo Fisher Scientific, Inc.	Sector (Health Care)	S&P500
3 Months	22.05%	4.5%	11.0%
6 Months	-7.97%	-7.9%	8.1%
1 Year	-19.59%	-12.3%	14.6%
3 Years	-11.83%	7.0%	58.7%

Thermo Fisher Scientific, Inc. Key Stats

Check Thermo Fisher Scientific key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$490.75
Open	$490.675
Today's High	$491.18
Today's Low	$487.0
Market Capitalization	$188.8B
Today's Volume	$1.0M
52 Week High	$627.88
52 Week Low	$385.46
Revenue TTM	$43.2B
EBITDA	$10.8B
Earnings Per Share (EPS)	$17.3
PE Ratio	28.9
Dividend Yield	0.34%
Profit Margin	15.24%
Quarterly Earnings Growth YOY	0.06%
Return On Equity TTM	13.42%

Stock Returns calculator for Thermo Fisher Scientific Stock including INR - Dollar returns

The Thermo Fisher Scientific stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Thermo Fisher Scientific investment value today

Current value as on today

₹84,572

Returns

₹15,428

(-15.43%)

Returns from Thermo Fisher Scientific Stock

₹19,956 (-19.96%)

Dollar Returns*

₹4,527 (+4.53%)

Indian investors sentiment towards Thermo Fisher Scientific Stock

-67.71%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Investment in Thermo Fisher Scientific Shares from India has dropped by -67.71% over the past 30 days, indicating reduced transactional activity.

-47%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Thermo Fisher Scientific Stock from India on INDmoney has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Thermo Fisher Scientific Stock

Name	Shares Held	Change in Shares	% of Assets
Axis Innovation Fund Direct Growth	1128	-82.29	0.39%
Motilal Oswal S&P 500 Index Fund Direct Growth	3051	-154.08	0.33%
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	11720	1169.30	1.47%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	595	0.00	1.47%

Global Institutional Holdings in Thermo Fisher Scientific, Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
8.95%
BlackRock Inc
7.70%
State Street Corp
4.38%
Morgan Stanley - Brokerage Accounts
3.07%
JPMorgan Chase & Co
2.68%
Capital World Investors
2.54%

Analyst Recommendation on Thermo Fisher Scientific Stock

Rating

Trend

Buy

68%Buy

31%Hold

0%Sell

Based on 32 Wall street analysts offering stock ratings for Thermo Fisher Scientific(by analysts ranked 0 to 5 stars)

Thermo Fisher Scientific Share Price Target

What analysts predicted

Upside of 13.05%

Target:

$552.38

Current:

$488.59

Thermo Fisher Scientific share price target is $552.38, a slight Upside of 13.05% compared to current price of $488.59 as per analysts' prediction.

Thermo Fisher Scientific Stock Insights

Price Movement
In the last 7 days, TMO stock has moved down by -1.5%
Increasing Revenue
Thermo Fisher Scientific, Inc. has shown positive revenue growth in the last two quarters. The company's revenue increased from $10.36 billion to $10.85 billion, reflecting an average rise of 4.5% per quarter.
Increasing Net Profit
Thermo Fisher Scientific, Inc. has shown positive profit trends over the last two quarters. The net profit increased from $1.50 billion to $1.61 billion, which represents an average growth of 6.8% per quarter.
TMO vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 32.5% return, outperforming this stock by 51.5%
TMO vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 83.3% return, outperforming this stock by 96.2%
Price to Sales
Thermo Fisher Scientific, Inc. has a Price-to-Sales Ratio of 4.3, meaning that investors are willing to pay $4.30 for every $1 of sales the company generates. In comparison, Idexx Laboratories, Inc. has a much higher Price-to-Sales Ratio of 12.9, indicating that investors are willing to pay $12.90 for every $1 of sales for that company.

Thermo Fisher Scientific, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$25.5B	↑ 4.86%
Net Income	$3.7B	↑ 25.8%
Net Profit Margin	14.47%	↑ 2.41%

	FY20	Y/Y Change
Revenue	$32.2B	↑ 26.14%
Net Income	$6.4B	↑ 72.48%
Net Profit Margin	19.79%	↑ 5.32%

	FY21	Y/Y Change
Revenue	$39.2B	↑ 21.71%
Net Income	$7.7B	↑ 21.18%
Net Profit Margin	19.7%	↓ 0.09%

	FY22	Y/Y Change
Revenue	$44.9B	↑ 14.55%
Net Income	$7.0B	↓ 10.03%
Net Profit Margin	15.47%	↓ 4.23%

	FY23	Y/Y Change
Revenue	$42.9B	↓ 4.58%
Net Income	$6.0B	↓ 13.74%
Net Profit Margin	13.99%	↓ 1.48%

	FY24	Y/Y Change
Revenue	$42.9B	↑ 0.05%
Net Income	$6.3B	↑ 5.67%
Net Profit Margin	14.77%	↑ 0.78%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$10.3B	↓ 4.97%
Net Income	$1.3B	↓ 18.53%
Net Profit Margin	12.84%	↓ 2.13%

	Q2 FY24	Q/Q Change
Revenue	$10.5B	↑ 1.89%
Net Income	$1.5B	↑ 16.57%
Net Profit Margin	14.69%	↑ 1.85%

	Q3 FY24	Q/Q Change
Revenue	$10.6B	↑ 0.54%
Net Income	$1.6B	↑ 5.3%
Net Profit Margin	15.38%	↑ 0.69%

	Q4 FY24	Q/Q Change
Revenue	$11.4B	↑ 7.52%
Net Income	$1.8B	↑ 12.27%
Net Profit Margin	16.06%	↑ 0.68%

	Q1 FY25	Q/Q Change
Revenue	$10.4B	↓ 9.05%
Net Income	$1.5B	↓ 17.65%
Net Profit Margin	14.54%	↓ 1.52%

	Q2 FY25	Q/Q Change
Revenue	$10.9B	↑ 4.74%
Net Income	$1.6B	↑ 7.3%
Net Profit Margin	14.9%	↑ 0.36%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$11.3B	↑ 3.24%

	FY20	Y/Y Change
Profit	$16.0B	↑ 41.28%

	FY21	Y/Y Change
Profit	$19.6B	↑ 22.51%

	FY22	Y/Y Change
Profit	$19.0B	↓ 3.17%

	FY23	Y/Y Change
Profit	$17.6B	↓ 7.62%

	FY24	Y/Y Change
Profit	$17.7B	↑ 0.95%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$4.2B	↑ 6.68%

	Q2 FY24	Q/Q Change
Profit	$4.3B	↑ 3.01%

	Q3 FY24	Q/Q Change
Profit	$4.3B	↓ 0.02%

	Q4 FY24	Q/Q Change
Profit	$4.5B	↑ 2.86%

	Q1 FY25	Q/Q Change
Profit	$4.2B	↓ 4.97%

	Q2 FY25	Q/Q Change
Profit	$4.0B	↓ 4.64%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$5.0B	↑ 9.47%
Investing Cash Flow	$-1.5B	↑ 18.68%
Financing Cash Flow	$-3.1B	↑ 39.38%

	FY20	Y/Y Change
Operating Cash Flow	$8.3B	↑ 66.68%
Investing Cash Flow	$-1.5B	↑ 1.55%
Financing Cash Flow	$959.0M	↓ 130.76%

	FY21	Y/Y Change
Operating Cash Flow	$9.5B	↑ 15.13%
Investing Cash Flow	$-21.9B	↑ 1352.45%
Financing Cash Flow	$6.6B	↑ 586.24%

	FY22	Y/Y Change
Operating Cash Flow	$9.2B	↓ 4.08%
Investing Cash Flow	$-2.2B	↓ 90.16%
Financing Cash Flow	$-2.8B	↓ 142.7%

	FY23	Y/Y Change
Operating Cash Flow	$8.4B	↓ 8.17%
Investing Cash Flow	$-5.1B	↑ 138.17%
Financing Cash Flow	$-3.6B	↑ 28.9%

	FY24	Y/Y Change
Operating Cash Flow	$8.7B	↑ 3.1%
Investing Cash Flow	$-5.8B	↑ 13.59%
Financing Cash Flow	$-6.8B	↑ 87.52%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$1.3B	↓ 66.4%
Investing Cash Flow	$-2.0B	↑ 439.89%
Financing Cash Flow	$-1.8B	↑ 27.52%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$2.0B	↑ 56.67%
Investing Cash Flow	$-253.0M	↓ 87.54%
Financing Cash Flow	$-114.0M	↓ 93.74%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$2.2B	↑ 10.51%
Investing Cash Flow	$-3.6B	↑ 1314.23%
Financing Cash Flow	$-1.2B	↑ 943.86%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$3.3B	↑ 51.89%
Investing Cash Flow	$20.0M	↓ 100.56%
Financing Cash Flow	$-3.7B	↑ 208.07%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$723.0M	↓ 78.02%
Investing Cash Flow	$-527.0M	↓ 2735.0%
Financing Cash Flow	$-102.0M	↓ 97.22%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$1.4B	↑ 93.5%
Investing Cash Flow	$-288.0M	↓ 45.35%
Financing Cash Flow	$-991.0M	↑ 871.57%

Thermo Fisher Scientific Technicals Summary

Sell

Neutral

Buy

Thermo Fisher Scientific is currently in a neutral trading position according to technical analysis indicators.

Thermo Fisher Scientific, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Thermo Fisher Scientific, Inc.	1.21%	-7.97%	-19.59%	-11.83%	15.63%
Danaher Corp.	2.37%	-0.81%	-22.72%	-24.92%	1.03%
Agilent Technologies Inc.	-0.36%	-11.42%	-15.58%	-7.03%	19.23%
Idexx Laboratories, Inc.	13.24%	40.12%	32.93%	83.78%	67.06%
Iqvia Holdings Inc.	-4.88%	-1.49%	-24.33%	-13.79%	16.68%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Thermo Fisher Scientific, Inc.	28.9	28.9	2.04	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	45.06	45.06	2.12	7.77	0.07	0.04	0.01	73.1
Agilent Technologies Inc.	29.35	29.35	1.79	5.58	0.19	0.08	0.01	21.61
Idexx Laboratories, Inc.	53.4	53.4	4.83	12.6	0.65	0.23	NA	18.2
Iqvia Holdings Inc.	27.25	27.25	1.1	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Thermo Fisher Scientific, Inc.	Buy	$188.8B	15.63%	28.9	15.24%
Danaher Corp.	Buy	$151.7B	1.03%	45.06	14.21%
Agilent Technologies Inc.	Buy	$33.8B	19.23%	29.35	17.59%
Idexx Laboratories, Inc.	Buy	$51.3B	67.06%	53.4	24.41%
Iqvia Holdings Inc.	Buy	$32.0B	16.68%	27.25	7.88%

Thermo Fisher Scientific Dividend announcements

Thermo Fisher Scientific Dividends September, 2025
In the quarter ending September,2025. Thermo Fisher Scientific has declared dividend of $0.43

About Thermo Fisher Scientific, Inc.

The Company was the product of a merger between parent companies Thermo Electron & Fisher Scientific in 2006. Among Thermo Electron's product offerings were analytical and laboratory instruments. Its revenues in 2004 totalled $2 billion. Fisher Scientific was founded in 1902. It provides laboratory equipment and associated services. The resultant Company is in the healthcare industry, specialising in diagnostic and research. The Company's segments are life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services. Over the years, 65 companies were acquired by Thermo Fisher Scientific, including 13 in just the past five years. Private equity firms funded approximately 22 acquisitions. Additionally, eight assets were divested. A $17.4 billion acquisition in 2021 was Thermo Fisher Scientific's largest acquisition to date. The most recent acquisitions are Mesa Biotech and the European Viral Vector business. Currently, the Company has more than 4,00,000 customers around the world. It has employed over 75,000 people. North America accounts for more than half of the Company's sales. The Company's core markets are pharmaceuticals, biotechs, diagnostics, health care, academics, and government. It stands in line with companies such as Abbott Laboratories, Becton Dickinson & Agilent Technologies. Currently Thermo Fisher Scientific, Inc. has a market cap of $233.66 Billion. It has a P.E ratio of 37.56. The shares of Thermo Fisher Scientific, Inc. are trading at $490.81. .

Organization	Thermo Fisher Scientific
Employees	125000
CEO	Mr. Marc N. Casper
Industry	Health Technology

Key Management of Thermo Fisher Scientific, Inc.

Name	Title
Mr. Marc N. Casper	Chairman, President & CEO
Mr. Stephen Williamson	Senior VP & CFO
Mr. Michel Lagarde	Executive VP & COO
Mr. Frederick M. Lowery	Executive VP and President of Laboratory Product & BioProduction
Mr. Gianluca Pettiti	Executive VP and President of Life Science, Diagnostics & Applied
Mr. Joseph R. Holmes	VP & Chief Accounting Officer
Mr. Ryan J. Snyder	Senior VP & Chief Information Officer
Dr. Karen E. Nelson Ph.D.	Chief Scientific Officer
Mr. Rafael Tejada	Vice President of Investor Relations
Mr. Thomas Bailey Shropshire Jr.	Senior VP and General Counsel

Important FAQs about investing in TMO Stock from India :

What is Thermo Fisher Scientific share price today?

Thermo Fisher Scientific share price today is $488.59 as on August 27, 2025 at 1:29 AM IST at the close of the market. Thermo Fisher Scientific share today touched a day high of $491.18 and a low of $487.00.

What is the 52 week high and 52 week low for Thermo Fisher Scientific share?

Thermo Fisher Scientific share touched a 52 week high of $627.88 and a 52 week low of $385.46. Thermo Fisher Scientific stock price today i.e. August 27, 2025 at 1:29 AM IST is closed at $488.59, lower by 22.18% versus the 52 week high.

How to invest in Thermo Fisher Scientific Stock (TMO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Thermo Fisher Scientific on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Thermo Fisher Scientific Shares that will get you 0.0031 shares as per Thermo Fisher Scientific share price of $488.59 per share as on August 27, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Thermo Fisher Scientific Stock (TMO) from India?

Indian investors can start investing in Thermo Fisher Scientific (TMO) shares with as little as ₹87.6525 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.53 in Thermo Fisher Scientific stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Thermo Fisher Scientific share’s latest price of $488.59 as on August 27, 2025 at 1:29 AM IST, you will get 0.0205 shares of Thermo Fisher Scientific. Learn more about fractional shares .

What are the returns that Thermo Fisher Scientific has given to Indian investors in the last 5 years?

Thermo Fisher Scientific stock has given 15.63% share price returns and 18.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?